GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$3.00
Tradestie Score
56
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+483.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.42
|
$202.58M | - | 53 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.98
|
$199.71M | - | 47 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$13.74
|
$170.45M | - | 53 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.92
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.44
|
$133.50M | - | 53 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$24.57
|
$117.07M | - | 47 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$18.85
|
$110.20M | - | 48 | Compare |
|
EUDA
EUDA Health Holdings Limited Ordinary Shares
|
$16.69
|
$73.94M | - | 51 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.33
|
$71.69M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.44
|
$67.94M | - | 59 | Compare |
More GNLX Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry